لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Wang X; Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Hayes JE; Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Program in Cancer Biology and Genetics and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Graduate School of Biomedical Sciences, Weill Cornell Medical College, New York, NY, United States., Xu X; Program in Cancer Biology and Genetics and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States; Graduate School of Biomedical Sciences, Weill Cornell Medical College, New York, NY, United States., Gao X; Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Program in Cancer Biology and Genetics and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States., Mehta D; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Lilja HG; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Departments of Laboratory Medicine and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK and Department of Translational Medicine, Lund University, Malmö, Sweden., Klein RJ; Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Program in Cancer Biology and Genetics and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. Electronic address: robert.klein@mssm.edu.

المصدر: Gene [Gene] 2021 Feb 05; Vol. 768, pp. 145265. Date of Electronic Publication: 2020 Oct 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0038 (Electronic) Linking ISSN: 03781119 NLM ISO Abbreviation: Gene Subsets: MEDLINE

مواضيع طبية MeSH: Genome-Wide Association Study*, Genetic Predisposition to Disease/*genetics , Nuclear Receptor Coactivators/*biosynthesis , Prostatic Neoplasms/*genetics , Prostatic Secretory Proteins/*genetics, CRISPR-Cas Systems/genetics ; Gene Deletion ; Gene Editing/methods ; Histone Code/genetics ; Humans ; Linkage Disequilibrium/genetics ; Male ; Nuclear Receptor Coactivators/genetics ; Polymorphism, Single Nucleotide/genetics ; Promoter Regions, Genetic/genetics ; RNA, Messenger/biosynthesis

المؤلفون: Darst BF; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. bdarst@usc.edu., Chou A; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Wan P; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Pooler L; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Sheng X; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Vertosick EA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Conti DV; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Wilkens LR; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii., Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Lilja HG; Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Translational Medicine, Lund University, Malmö, Sweden., Haiman CA; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Jul; Vol. 29 (7), pp. 1381-1388. Date of Electronic Publication: 2020 May 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: Kallikreins/*metabolism , Prostatic Neoplasms/*epidemiology, Aged ; Aged, 80 and over ; Case-Control Studies ; Early Detection of Cancer ; Humans ; Male ; Middle Aged ; Prospective Studies

المؤلفون: Thorek DLJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University, St. Louis, Missouri., Ku AT; Division of Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.; Clinical Research Center, Lund University, Malmö, Sweden., Mitsiades N; Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Veach D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medical College, New York, New York., Watson PA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Metha D; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Strand SE; Division of Oncology and Pathology, and Medical Radiation Physics, Department of Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden., Sharma SK; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Lewis JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medical College, New York, New York.; Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Abou DS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri., Lilja HG; Departments of Laboratory Medicine, Surgery and Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Nuffield Department of Surgical Sciences, Oxford University, John Radcliffe Hospital, Headington, Oxford, United Kingdom.; Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Larson SM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medical College, New York, New York.; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., McDevitt MR; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medical College, New York, New York., Ulmert D; Division of Oncology and Pathology, and Medical Radiation Physics, Department of Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden. HUlmert@mednet.ucla.edu.; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, California.; Jonsson Comprehensive Cancer Center, David Geffen UCLA School of Medicine, Los Angeles, California.; Ahmanson Translational Imaging Division, David Geffen UCLA School of Medicine, Los Angeles, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jan 15; Vol. 25 (2), pp. 881-891. Date of Electronic Publication: 2018 Sep 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction*/drug effects , Signal Transduction*/radiation effects, Alpha Particles/*therapeutic use , Breast Neoplasms/*metabolism , Immunoconjugates/*administration & dosage , Receptors, Androgen/*metabolism, Animals ; Biomarkers, Tumor ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Cell Line, Tumor ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Dose-Response Relationship, Radiation ; Female ; Hexokinase/antagonists & inhibitors ; Humans ; Immunoconjugates/pharmacokinetics ; Mice ; Molecular Targeted Therapy ; Radioimmunotherapy ; Radiometry ; Tissue Distribution ; Xenograft Model Antitumor Assays

المؤلفون: Kallio HML; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. heini.kallio@uta.fi., Hieta R; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Latonen L; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Brofeldt A; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Annala M; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Kivinummi K; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Tammela TL; Department of Urology, University of Tampere, Tampere University Hospital, Tampere, Finland., Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Isaacs WB; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Lilja HG; Departments of Surgery (Urology), Laboratory Medicine and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Department of Translational Medicine, Lund University, Malmö, Sweden.; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Bova GS; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland., Visakorpi T; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.

المصدر: British journal of cancer [Br J Cancer] 2018 Aug; Vol. 119 (3), pp. 347-356. Date of Electronic Publication: 2018 Jul 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer

مواضيع طبية MeSH: Prostatic Hyperplasia/*genetics , Prostatic Neoplasms, Castration-Resistant/*genetics , Protein Isoforms/*genetics , Receptors, Androgen/*genetics, Androgens/genetics ; Cell Line, Tumor ; DNA Copy Number Variations/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Male ; Neoplasm Metastasis ; Prostate/metabolism ; Prostate/pathology ; Prostatic Hyperplasia/pathology ; Prostatic Hyperplasia/surgery ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/surgery ; RNA Splicing/genetics ; Exome Sequencing ; Whole Genome Sequencing

المؤلفون: Vedder MM; Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands. Electronic address: m.vedder@erasmusmc.nl., de Bekker-Grob EW; Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands., Lilja HG; Departments of Surgery (Urology), Laboratory Medicine, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Laboratory Medicine and Clinical Sciences in Malmö, Lund University, Skåne University Hospital, Malmö, Sweden; Institute of Biomedical Technology, University of Tampere, Tampere, Finland., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., van Leenders GJ; Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands., Steyerberg EW; Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands.

المصدر: European urology [Eur Urol] 2014 Dec; Vol. 66 (6), pp. 1109-15. Date of Electronic Publication: 2014 Aug 26.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*blood , Biomarkers, Tumor/*blood , Early Detection of Cancer/*methods , Kallikreins/*blood , Prostate-Specific Antigen/*blood , Prostatic Neoplasms/*diagnosis, Aged ; Area Under Curve ; Biopsy ; Digital Rectal Examination ; Humans ; Male ; Models, Statistical ; Multivariate Analysis ; Netherlands ; Prostate/pathology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnostic imaging ; ROC Curve ; Risk Assessment/methods ; Ultrasonography

المؤلفون: Taylor JM; Protein Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P

المصدر: Proteomics. Clinical applications [Proteomics Clin Appl] 2014 Jun; Vol. 8 (5-6), pp. 317-26. Date of Electronic Publication: 2014 Mar 31.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101298608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1862-8354 (Electronic) Linking ISSN: 18628346 NLM ISO Abbreviation: Proteomics Clin Appl Subsets: MEDLINE

مواضيع طبية MeSH: Aminopeptidases/*urine , Biomarkers, Tumor/*urine , Proteomics/*methods , Urinary Bladder Neoplasms/*enzymology , Urinary Bladder Neoplasms/*urine, Female ; Humans ; Male ; Prognosis ; Prospective Studies ; Urinary Bladder Neoplasms/diagnosis

المؤلفون: Vucetic Z; Fujirebio Diagnostics Inc, Malvern, PA, USA., Dnistrian A, Nilsson O, Lilja HG, Plebani M

المصدر: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2013 Apr; Vol. 51 (4), pp. 873-80.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE

مواضيع طبية MeSH: Immunoassay*/standards, Biomarkers, Tumor/*blood , Prostate-Specific Antigen/*blood , Prostatic Neoplasms/*diagnosis, Biomarkers, Tumor/standards ; Humans ; Male ; Prostate-Specific Antigen/standards ; Quality Control

المؤلفون: Zhang L; Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA. zhangl2@mskcc.org, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL

المصدر: The American journal of pathology [Am J Pathol] 2009 Aug; Vol. 175 (2), pp. 489-99. Date of Electronic Publication: 2009 Jul 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0370502 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-2191 (Electronic) Linking ISSN: 00029440 NLM ISO Abbreviation: Am J Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic*, NF-kappa B/*metabolism , Prostatic Neoplasms/*pathology , Receptors, Androgen/*genetics, Animals ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Cell Proliferation ; Humans ; Male ; Mice ; Mice, Nude ; NF-kappa B/antagonists & inhibitors ; Promoter Regions, Genetic ; Prostatic Neoplasms/genetics ; Sesquiterpenes/pharmacology ; Transcription Factor RelA/antagonists & inhibitors ; Transcription Factor RelA/metabolism ; Xenograft Model Antitumor Assays